LORI, ELISA MARIA
LORI, ELISA MARIA
Dipartimento di Scienze Biomediche e Cliniche
Evaluation of the effect of protective genetic variants on cART success in HIV-1-infected patients
2020 E.M. Lori, A. Cozzi-Lepri, A. Tavelli, V. Mercurio, S.V. Ibba, S. Lo Caputo, F. Castelli, A. Castagna, A. Gori, G. Marchetti, C. Venditti, M. Clerici, A. D'Arminio Monforte, M. Biasin
DISSECTING ERAP2 ROLE IN HIV-1 INFECTION
2019 E.M. Lori
The Biological Foundations of Sarcopenia: Established and Promising Markers
2019 M. Casati, A.S. Costa, D. Capitanio, L. Ponzoni, E. Ferri, S. Agostini, E. Lori
Endoplasmic Reticulum Associated Aminopeptidase 2 (ERAP2) is released in the secretome of activated MDMs and reduces in vitro HIV-1 infection
2019 I. Saulle, S.V. Ibba, E. Torretta, C. Vittori, C. Fenizia, F. Piancone, D. Minisci, E.M. Lori, D. Trabattoni, C. Gelfi, M. Clerici, M. Biasin
The interleukin 21 (IL 21)/ microRNA-29 (miR-29) axis is associated with natural resistance to HIV-1 infection
2018 P.A.S. Ortega, I. Saulle, V. Mercurio, S.V. Ibba, E.M. Lori, C. Fenizia, M. Masetti, D. Trabattoni, S.L. Caputo, F. Vichi, F. Mazzotta, M. Clerici, M. Biasin